A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis
- PMID: 19283306
- DOI: 10.3414/ME0535
A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis
Abstract
Objectives: In a literature-based meta-analysis for time-to-event data, the hazard ratio in each trial is often estimated from the summary statistics described in the article. Several methods have been proposed: the direct method (Peto method); the indirect method using a p-value by the log-rank test and the number of total events; and the survival curve method using the Kaplan-Meier estimate. However, there has been no published report on a detailed investigation of these methods. We evaluated the performance of these methods by simulation.
Methods: In a set of simulation experiments, performance of five methods was evaluated by the bias of estimated log hazard ratio and coverage probability of the confidence interval. The methods evaluated were: 1) Cox regression analysis, 2) direct method, 3) indirect method, 4) survival curve method, and 5) modified survival curve method with an alternative weighting scheme.
Results: The direct method was confirmed to have a high degree of accuracy. Although the indirect method was also highly accurate, it tended to underestimate effect size when there was a strong effect. The survival curve method tended to underestimate effect size when event numbers were small and effect size was large. The modified survival curve method could alleviate this tendency toward underestimation of effect size found with the original survival curve method.
Conclusions: When the Kaplan-Meier curve is used to estimate hazard ratios in trials with small sample size in the literature-based meta-analysis, we should check critically whether those trials' hazard ratios and overall hazard ratio are underestimated or not.
Similar articles
-
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.BMC Med Res Methodol. 2016 Mar 29;16:37. doi: 10.1186/s12874-016-0137-z. BMC Med Res Methodol. 2016. PMID: 27025706 Free PMC article.
-
Application of a hazard-based visual predictive check to evaluate parametric hazard models.J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):57-71. doi: 10.1007/s10928-015-9454-9. Epub 2015 Nov 13. J Pharmacokinet Pharmacodyn. 2016. PMID: 26563504
-
On confidence intervals for the hazard ratio in randomized clinical trials.Biometrics. 2016 Dec;72(4):1098-1102. doi: 10.1111/biom.12528. Epub 2016 Apr 28. Biometrics. 2016. PMID: 27123760 Free PMC article.
-
Are non-constant rates and non-proportional treatment effects accounted for in the design and analysis of randomised controlled trials? A review of current practice.BMC Med Res Methodol. 2019 May 16;19(1):103. doi: 10.1186/s12874-019-0749-1. BMC Med Res Methodol. 2019. PMID: 31096924 Free PMC article. Review.
-
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week.J Am Coll Cardiol. 2019 Oct 22;74(16):2102-2112. doi: 10.1016/j.jacc.2019.08.1034. J Am Coll Cardiol. 2019. PMID: 31623769 Review.
Cited by
-
Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance.Syst Rev. 2025 Apr 10;14(1):84. doi: 10.1186/s13643-025-02752-z. Syst Rev. 2025. PMID: 40211371 Free PMC article.
-
Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.PLoS One. 2017 Sep 21;12(9):e0184597. doi: 10.1371/journal.pone.0184597. eCollection 2017. PLoS One. 2017. PMID: 28934265 Free PMC article.
-
Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.J Neurooncol. 2011 Nov;105(2):325-35. doi: 10.1007/s11060-011-0594-5. Epub 2011 Apr 27. J Neurooncol. 2011. PMID: 21523485
-
Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis.PLoS One. 2013 Oct 18;8(10):e76719. doi: 10.1371/journal.pone.0076719. eCollection 2013. PLoS One. 2013. PMID: 24204662 Free PMC article.
-
Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.PLoS Med. 2020 Jan 31;17(1):e1003019. doi: 10.1371/journal.pmed.1003019. eCollection 2020 Jan. PLoS Med. 2020. PMID: 32004320 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources